What factors should be considered when determining if a patient is eligible for ruxolitinib for vitiligo?
Featuring Cheri Frey, MD |
Assistant Professor, Dermatology & Residency Program Director
Director of Cosmentic Dermatology
Howard University
Washington, DC
Related CME
Related Media
Powered by Polaris TM